Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML

Abstract The pathways and robust deregulated gene signatures involved in AML chemo-resistance are not fully understood. Multiple subgroups of AMLs which are under treatment of various regimens seem to have similar regulatory gene(s) or pathway(s) related to their chemo-resistance phenotype. In this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Parastoo Modarres, Farzaneh Mohamadi Farsani, Amir Abas Nekouie, Sadeq Vallian
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a59b6b2f338847b0a12172c886070653
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a59b6b2f338847b0a12172c886070653
record_format dspace
spelling oai:doaj.org-article:a59b6b2f338847b0a12172c8860706532021-12-02T16:04:26ZMeta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML10.1038/s41598-021-91864-22045-2322https://doaj.org/article/a59b6b2f338847b0a12172c8860706532021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91864-2https://doaj.org/toc/2045-2322Abstract The pathways and robust deregulated gene signatures involved in AML chemo-resistance are not fully understood. Multiple subgroups of AMLs which are under treatment of various regimens seem to have similar regulatory gene(s) or pathway(s) related to their chemo-resistance phenotype. In this study using gene set enrichment approach, deregulated genes and pathways associated with relapse after chemotherapy were investigated in AML samples. Five AML libraries compiled from GEO and ArrayExpress repositories were used to identify significantly differentially expressed genes between chemo-resistance and chemo-sensitive groups. Functional and pathway enrichment analysis of differentially expressed genes was performed to assess molecular mechanisms related to AML chemotherapeutic resistance. A total of 34 genes selected to be differentially expressed in the chemo-resistance compared to the chemo-sensitive group. Among the genes selected, c-Jun, AKT3, ARAP3, GABBR1, PELI2 and SORT1 are involved in neurotrophin, estrogen, cAMP and Toll-like receptor signaling pathways. All these pathways are located upstream and regulate JNK signaling pathway which functions as a key regulator of cellular apoptosis. Our expression data are in favor of suppression of JNK pathway, which could induce pro-apoptotic gene expression as well as down regulation of survival factors, introducing this pathway as a key regulator of drug-resistance development in AML.Parastoo ModarresFarzaneh Mohamadi FarsaniAmir Abas NekouieSadeq VallianNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Parastoo Modarres
Farzaneh Mohamadi Farsani
Amir Abas Nekouie
Sadeq Vallian
Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
description Abstract The pathways and robust deregulated gene signatures involved in AML chemo-resistance are not fully understood. Multiple subgroups of AMLs which are under treatment of various regimens seem to have similar regulatory gene(s) or pathway(s) related to their chemo-resistance phenotype. In this study using gene set enrichment approach, deregulated genes and pathways associated with relapse after chemotherapy were investigated in AML samples. Five AML libraries compiled from GEO and ArrayExpress repositories were used to identify significantly differentially expressed genes between chemo-resistance and chemo-sensitive groups. Functional and pathway enrichment analysis of differentially expressed genes was performed to assess molecular mechanisms related to AML chemotherapeutic resistance. A total of 34 genes selected to be differentially expressed in the chemo-resistance compared to the chemo-sensitive group. Among the genes selected, c-Jun, AKT3, ARAP3, GABBR1, PELI2 and SORT1 are involved in neurotrophin, estrogen, cAMP and Toll-like receptor signaling pathways. All these pathways are located upstream and regulate JNK signaling pathway which functions as a key regulator of cellular apoptosis. Our expression data are in favor of suppression of JNK pathway, which could induce pro-apoptotic gene expression as well as down regulation of survival factors, introducing this pathway as a key regulator of drug-resistance development in AML.
format article
author Parastoo Modarres
Farzaneh Mohamadi Farsani
Amir Abas Nekouie
Sadeq Vallian
author_facet Parastoo Modarres
Farzaneh Mohamadi Farsani
Amir Abas Nekouie
Sadeq Vallian
author_sort Parastoo Modarres
title Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
title_short Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
title_full Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
title_fullStr Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
title_full_unstemmed Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
title_sort meta-analysis of gene signatures and key pathways indicates suppression of jnk pathway as a regulator of chemo-resistance in aml
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a59b6b2f338847b0a12172c886070653
work_keys_str_mv AT parastoomodarres metaanalysisofgenesignaturesandkeypathwaysindicatessuppressionofjnkpathwayasaregulatorofchemoresistanceinaml
AT farzanehmohamadifarsani metaanalysisofgenesignaturesandkeypathwaysindicatessuppressionofjnkpathwayasaregulatorofchemoresistanceinaml
AT amirabasnekouie metaanalysisofgenesignaturesandkeypathwaysindicatessuppressionofjnkpathwayasaregulatorofchemoresistanceinaml
AT sadeqvallian metaanalysisofgenesignaturesandkeypathwaysindicatessuppressionofjnkpathwayasaregulatorofchemoresistanceinaml
_version_ 1718385224227749888